Who is managing acute decompensated heart failure? The need for a multidisciplinary approach

Journal of Hospital Medicine

Volumn 3, Issue SUPPL 6, 2008, Pages

  Amin, Alpesh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; AFTERCARE; ALGORITHM; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEART FAILURE; HOSPITAL; HUMAN; INTERDISCIPLINARY COMMUNICATION; MEDICAL STAFF; PATIENT CARE; PHYSICIAN ATTITUDE; REVIEW; STANDARD;

ACUTE DISEASE; AFTERCARE; ALGORITHMS; CONTINUITY OF PATIENT CARE; EVIDENCE-BASED MEDICINE; HEART FAILURE; HOSPITALISTS; HOSPITALS; HUMANS; INTERDISCIPLINARY COMMUNICATION; PATIENT CARE MANAGEMENT; PHYSICIAN'S ROLE; QUALITY ASSURANCE, HEALTH CARE;

EID: 61849162849     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.394     Document Type: Note

References (62)

1. Graves EJ, Kozak LJ. National Hospital Discharge Survey: annual summary, 1996. Vital Health Stat. 1999; 13(140): 1-46.
2. Haldeman GA, Croft JB, Giles WH, Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J. 1999; 137(2): 352-360.
3. Kozak LJ, Owings MF, Hall MJ. National Hospital Discharge Survey: 2001 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 2004; 13(156): 1-198.
4. Kozak LJ, Owings MF, Hall MJ. National Hospital Discharge Survey: 2002 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 2005; 13(158): 1-199.
5. DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 2007; 13(165): 1-209.
6. Kozak LJ, DeFrances CJ, Hall MJ. National Hospital Discharge Survey: 2004 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 2006; 13(162): 1-209.
7. Kozak LJ, Lees KA, DeFrances CJ. National Hospital Discharge Survey: 2003 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 2006; 13(160): 1-206.
8. Division for Heart Disease and Stroke Prevention. Heart failure fact sheet. Available at: http://www.cdc.gov/dhdsp/library/fs_heart_failure_longdesc.htm. Accessed September 2008.
9. US Census Bureau. Projected population of the United States, by age and sex: 2000 to 2050. Available at: http://www.census.gov/population/www/projections/usinterimproj/natprojtab02a.pdf. Accessed September 2008.
10. Foot DK, Lewis RP, Pearson TA, Beller GA. Demographics and cardiology, 1950-2050. J Am Coll Cardiol. 2000; 35(4): 1067-1081.
11. 35th Bethesda Conference. Cardiology's workforce crisis: a pragmatic approach. Bethesda, Maryland, 17-18 October 2003. J Am Coll Cardiol. 2004; 44(2): 216-275.
12. Baudendistel TE, Wachter RM. The evolution of the hospitalist movement in the USA. Clin Med. 2002; 2(4): 327-330.
13. Wachter RM. Hospitalists in the United States-mission accomplished or work in progress? N Engl J Med. 2004; 350(19): 1935-1936.
14. Amin AN. Identifying strategies to improve outcomes and reduce costs-a role for the hospitalist. Curr Opin Pulm Med. 2004; 10( suppl): S19-S22.
15. Bonow RO, Smith SCJr. Cardiovascular manpower: the looming crisis. Circulation. 2004; 109(7): 817-820.
16. Kereiakes DJ, Willerson JT. The United States cardiovascular care deficit. Circulation. 2004; 109(7): 821-823.
17. Heart Failure Society of America. Evaluation and management of patients with acute decompensated heart failure. J Card Fail. 2006; 12(1): e86-e103.
18. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study. Arch Intern Med. 1999; 159(16): 1939-1945.
19. Ducharme A, Doyon O, White M, Rouleau JL, Brophy JM. Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial. CMAJ. 2005; 173(1): 40-45.
20. Knox D, Mischke L. Implementing a congestive heart failure disease management program to decrease length of stay and cost. J Cardiovasc Nurs. 1999; 14(1): 55-74.
21. Pistoria MJ, Amin AN, Dressler DD, McKean SCW, Budnitz TL. The core competencies in hospital medicine: a framework for curriculum development by the Society of Hospital Medicine. J Hosp Med. 2006; 1( suppl 1): 2-95.
22. Cobaugh DJ, Amin A, Brookwalter T, et al. ASHP-SHM joint statement on hospitalist-pharmacist collaboration. J Hosp Med. 2008; 3( suppl 3). doi://10.1002/jhm.315. Available at: http://www3.interscience.wiley.com.
23. Kay D, Blue A, Pye P, Lacy A, Gray C, Moore S. Heart failure: improving the continuum of care. Care Manag J. 2006; 7(2): 58-63.
24. Berkowitz R, Blank LJ, Powell SK. Strategies to reduce hospitalization in the management of heart failure. Lippincotts Case Manag. 2005; 10(6 suppl): S1-S15.
25. Amin A. Improving the management of patients after myocardial infarction, from admission to discharge. Clin Ther. 2006; 28(10): 1509-1539.
26. Amin AN. The role of hospitalists in the management of acute decompensated heart failure. Am Heart Hosp J. 2005; 3(2): 111-117.
27. Lindenauer PK, Chehabeddine R, Pekow P, Fitzgerald J, Benjamin EM. Quality of care for patients hospitalized with heart failure: assessing the impact of hospitalists. Arch Intern Med. 2002; 162(11): 1251-1256.
28. Amin AN, Owen MM. Productive interdisciplinary team relationships: the hospitalist and the case manager. Lippincotts Case Manag. 2006; 11(3): 160-164.
29. Collier VU. Use of pay for performance in a community hospital private hospitalist group: a preliminary report. Trans Am Clin Climatol Assoc. 2007; 118: 263-272.
30. Roytman MM, Thomas SM, Jiang CS. Comparison of practice patterns of hospitalists and community physicians in the care of patients with congestive heart failure. J Hosp Med. 2008; 3(1): 35-41.
31. Ozdas A, Speroff T, Waitman LR, Ozbolt J, Butler J, Miller RA. Integrating "best of care" protocols into clinicians' workflow via care provider order entry: impact on quality-of-care indicators for acute myocardial infarction. J Am Med Inform Assoc. 2006; 13(2): 188-196.
32. Butler J, Speroff T, Arbogast PG, et al. Improved compliance with quality measures at hospital discharge with a computerized physician order entry system. Am Heart J. 2006; 151(3): 643-653.
33. Kripalani S, Jackson AT, Schnipper JL, Coleman EA. Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists. J Hosp Med. 2007; 2(5): 314-323.
34. Cornish PL, Knowles SR, Marchesano R, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005; 165(4): 424-429.
35. Gleason KM, Groszek JM, Sullivan C, Rooney D, Barnard C, Noskin GA. Reconciliation of discrepancies in medication histories and admission orders of newly hospitalized patients. Am J Health Syst Pharm. 2004; 61(16): 1689-1695.
36. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006; 166(5): 565-571.
37. Joint Commission on Accreditation of Healthcare Organizations. Using medication reconciliation to prevent errors. Sentinel Event Alert #35. Available at: http://www.jointcommission.org/sentinelevents/sentineleventalert/sea_35.htm. Accessed September 2008.
38. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure: traits among urban blacks. Arch Intern Med. 1988; 148(9): 2013-2016.
39. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990; 38(12): 1290-1295.
40. Peacock WF4th, Albert NM. Observation unit management of heart failure. Emerg Med Clin North Am. 2001; 19(1): 209-232.
41. Adams KFJr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Failure National Registry (ADHERE). Am Heart J. 2005; 149(2): 209-216.
42. Gheorghiade M, Abraham WT, Albert NM, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006; 296(18): 2217-2226.
43. Katz PS. Eliminating drug errors: hospitals adopt medication reconciliation to improve patient safety. Available at: http://www.acponline.org/clinical_information/journals_publications/acp_hospitalist/may07/drug_errors.htm. Accessed September 2008.
44. Butler J, Arbogast PG, BeLue R, et al. Outpatient adherence to beta-blocker therapy after acute myocardial infarction. JAm Coll Cardiol. 2002; 40(9): 1589-1595.
45. Gattis WA, O'Connor CM. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure. Am J Cardiol. 2004; 93(9A): 74B-76B.
46. Fonarow GC, Gawlinski A, Moughrabi S, Tillisch JH. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol. 2001; 87(7): 819-822.
47. Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007; 297(1): 61-70.
48. deGoma EM, Vagelos RH, Fowler MB, Ashley EA. Emerging therapies for the management of decompensated heart failure: from bench to bedside. J Am Coll Cardiol. 2006; 48(12): 2397-2409.
49. Tang WHW, Hobbs RE. Novel strategies for the management of acute decompensated heart failure. Curr Cardiol Rev. 2005; 1(1): 1-5.
50. Konstam MA, Gheorghiade M, Burnett JCJr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA. 2007; 297(12): 1319-1331.
51. Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006; 355(20): 2099-2112.
52. Schweiger TA, Zdanowicz MM. Vasopressin-receptor antagonists in heart failure. Am J Health Syst Pharm. 2008; 65(9): 807-817.
53. Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC. The effects of KW-3902, an adenosine A1-receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol. 2007; 50(16): 1551-1560.
54. 1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol. 2007; 50(7): 600-606.
55. McMurray JJ, Teerlink JR, Cotter G, et al. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA. 2007; 298(17): 2009-2019.
56. CK-1827452. Cytokinetics Web site. Available at: http://www.cytokinetics.com/ck_1827452. Accessed September 2008.
57. Blair JE, Macarie C, Ruzyllo W, et al. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial. Am J Ther. 2008; 15(3): 231-240.
58. Cleland JG, Coletta AP, Yassin A, et al. Clinical trials update from the American College of Cardiology 2008: CARISMA, TRENDS, meta-analysis of Cox-2 studies, HAT, ON-TARGET, HYVET, ACCOMPLISH, MOMENTUM, PROTECT, HORIZON-HF and REVERSE. Eur J Heart Fail. 2008; 10(6): 614-620.
59. Mitrovic V, Seferovic PM, Simeunovic D, et al. Haemodynamic and clinical effects of ularitide in decompensated heart failure. Eur Heart J. 2006; 27(23): 2823-2832.
60. Brieke A, Cleveland JJr, Lindenfeld J. Mechanical support in acute and chronic heart failure. Curr Cardiol Rep. 2008; 10(3): 168-175.
61. Kale P, Fang JC. Devices in acute heart failure. Crit Care Med. 2008; 36(1 suppl): S121-S128.
62. Allen LA, Felker GM. Advances in the surgical treatment of heart failure. Curr Opin Cardiol. 2008; 23(3): 249-253.